Company profile
The Oncology Institute, Inc.
NASDAQ: TOI · Healthcare · Medical - Care Facilities
#211 of 1,422 Healthcare companies by revenue71st-percentile growth
EA Score
52DFH 53DQ 34GM 77SS 63
v0.1 · 65/100 weight · provisional
↑ growth stability, workforce scale · ↓ Piotroski F, disclosure history
Methodology →Revenue TTM
$545.8M
Rev growth YoY (TTM)
+35.4%
Net income (FY)
-$60.6M
Employees
641
as of 2026-08-11
Market cap
$512.9M
as of 2026-08-11
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$502.7M$502.7M2025
Net income-$60.6M-$60.6M2025
Operating income-$36.1M-$36.1M2025
Total assets$164.7M$164.7M2025
Liabilities$180.4M$180.4M2025
Equity-$15.7M-$15.7M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Health Care, Patient Service50%
Fee For Service32%
Capitated Revenue17%
Clinical Research Trials And Other Revenue1%
By geography
Not disclosed.
The read
What is The Oncology Institute, Inc.’s revenue?
The Oncology Institute, Inc. booked $502.7M in FY2025 revenue, growing 28% year over year — faster than most Healthcare companies we track, at a -12.1% net margin.
Peers · Healthcare
Inotiv, Inc.63CADMA Biologics, Inc.85AGlaukos Corporation71BBridgeBio Pharma, Inc.53DAscend Wellness Holdings, Inc.53DInyx, Inc.——Neighbors
Los Angeles →Key facts
CEODaniel Virnich
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersCerritos, CA
ExchangeNASDAQ: TOI
Employees641
IPO date2020-06-04
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.